Surrogate endpoints with Huseyin Naci

Surrogate endpoints with Huseyin Naci

BMJ talk medicine

This week, we’re joined by Huseyin Naci to discuss the recent press release from Eisai and Biogen announcing the Phase III trial results for lecanemab for use in Alzheimer’s disease, and the FDA’s decision to accept the …

Related tracks

See all